Vitamin markets: High prices for vitamin D due to material shortages
The current high prices of vitamin D3 show no signs of decreasing, with material shortages persisting and suppliers standing firm on their pricing strategies. Learn more in this week’s feed additives snapshot (week 3).
In partnership with Feed Additive Prices
Vitamin E 50%
The market remains notably quiet and relatively stable, maintaining elevated price levels. Numerous production maintenance periods have been scheduled for the upcoming weeks and months, yet these announcements have yet to impact market dynamics. While contracts for Q1 are secured, there is currently a lack of significant interest for Q2.
Vitamin A 1000
The step-by-step price decline is still seen, although this week the price has been fairly stable. New capacity ex China is on the way but that might still take some time before that is all approved and shipped. For now, a stable to slightly weaker trend is expected for the coming period. Q1 is contracted, Q2 mostly open still.
Vitamin D3 500
The current high prices of vitamin D3 show no signs of decreasing, with material shortages persisting and suppliers standing firm on their pricing strategies. Recently, one of the major suppliers announced yet another price increase, but the market has remained unresponsive thus far. Some buyers will need to re-enter the market in the first quarter to secure additional volume, as their initial wait-and-see approach has led them to recognize that a short-term price decrease is unlikely. A significant portion of the first quarter’s supply is already contracted.
Vitamin B2 80%
In Europe, recent supply chain tightness among Western manufacturers had caused delivery delays and slight price increases, but that seems to have improved now. Other regions report good availability and mostly stable prices, with no significant changes anticipated and most contracts for the first quarter already secured.
D-Calpan
Relatively static market. Prices remain stable at a relatively low level and that goes for all regions. As there is an oversupply situation for this product, no signs of nearby change are expected. A good portion of Q1 is contracted.
Vitamin B3
Several suppliers remain eager to raise prices, while some others aim to maintain or expand their market share by offering competitive pricing. Consequently, the market has shown no significant changes compared to the previous weeks. Most buyers have already fulfilled their requirements for the first quarter, resulting in a relatively quiet market atmosphere.
Biotin
No signs of any sort of change in the biotin market are seen or reported. Very static market at the moment. New additional production capacity in China has recently been announced for 2025. A good portion of Q1 is contracted.
Vitamin C 35% mono
The market has remained largely static for several weeks, with many suppliers maintaining pressure for higher prices or opting not to provide offers at all. Prices are generally stable, transaction volumes are very low, and there is a lack of urgency for purchasing new materials. Overall, activity in the market has been quite subdued, with a significant portion of first-quarter contracts already secured and some extending into the second quarter.
